Company attributes
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
Orum Therapeutics, Inc.
Legal classification
Number of Employees (Ranges)
11 – 50
Full Address
Orum Therapeutics, 20 Acorn Park Drive Ste 501 Cambridge, MA 02140
18F, Gangnam-daero 382, Gangnam-gu, Seoul, South Korea, 06232
2F, 281-25 Munji-ro, Yuseong-Gu, Daejeon, South Korea, 34050
Investors
Total Funding Amount (USD)
38,000,000
Latest Funding Round Date
July 2019
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Orum Therapeutics is a private biotech company developing a class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its cell-penetrating antibody platform, called Oromab, to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
